Sulforidazine
From Wikipedia, the free encyclopedia
Sulforidazine
|
|
Systematic (IUPAC) name | |
10-[2-(1-methyl-2-piperidyl)ethyl]- 2-methylsulfonyl-phenothiazine | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C21H26N2O2S2 |
Mol. mass | 402.575 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Sulforidazine (Imagotan®, Psychoson®, Inofal®) a typical antipsychotic and a metabolite of thioridazine; it and mesoridazine are more potent than the parent compound, whose pharmacological effects are believed by some to be largely due to its metabolism into sulforidazine and mesoridazine.[1]
[edit] References
- ^ Niedzwiecki DM, Mailman RB, Cubeddu LX (Mar 1984). "Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors". Journal of Pharmacology & Experimental Therapeutics 228 (3): 636-9. PMID 6707914.
- PubChem Substance Summary: Sulforidazine National Center for Biotechnology Information.